Search the Newsreel

Pediatrix Medical Group (MD) director receives 472-share restricted stock grant

John M. Starcher Jr., a director at Pediatrix Medical Group (MD), was granted 472 restricted shares of common stock on August 12, 2026. These shares, valued at $26.50 each, are part of the company's incentive compensation plan and will vest on May 7, 2027. …

Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings

Pediatrix Medical Group director Thomas McEachin was granted 472 restricted shares of common stock on August 12, 2026, valued at $26.50 per share, under the company's incentive plan. These shares will vest on May 7, 2027. Following this transaction, his direct holdings increased to …

Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone

Pediatrix Medical Group (MD) director Guy P. Sansone received an equity award of 472 restricted shares on August 12, 2026, priced at $26.50 per share. These shares, granted under the company's Second Amended and Restated 2008 Incentive Compensation Plan, will vest on May 7, …

Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside

The average 12-month price target for Pediatrix Medical Group, Inc. (MD) stock has been lowered from $26.17 to $26 by 5 analysts, with a range of $21 to $28 per share. This new target suggests a potential 2% downside from the August 12 closing …

Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD

Wasatch Advisors LP increased its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 21.9% in the second quarter, holding 2.50 million shares valued at approximately $63.3 million. Institutional investors now own 97.71% of the company's stock, which recently reported strong quarterly earnings, beating revenue …

Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Mark Ordan Chief Financial Officer - Kasandra Rossi Full Conference Call Transcript Operator: Thank you for standing by. My name is Jordan, and I'll …

Asesoramos a YPF en la venta de su participación en MetroGAS y MetroENERGÍA a Edenor

Bruchou & Funes de Rioja advised YPF S.A. on the sale of its 70% stake in MetroGAS S.A. and 5% in MetroENERGÍA S.A. to Empresa Distribuidora y Comercializadora Norte S.A. (EDENOR). The transaction, which followed a competitive process organized by Citibank N.A., is pending …

edenor (NYSE: EDN) boosts operating profit, expands debt and bids for Metrogas

Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions

Pediatrix Medical Group (MD) has seen an 89% share price return over the past year, yet its stock appears undervalued based on several valuation metrics, including a P/E ratio significantly below the healthcare sector average. Despite a recent share price drop post-earnings, the company …

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) (NYSE:EDN) Announces Earnings Results

Edenor (NYSE: EDN) lifts EBITDA, posts ARS 157B net profit in 6M26

Empresa: Q2 Earnings Snapshot

Edenor (NYSE: EDN) gains AA-(arg) rating and Positive Outlook from FIX

Empresa Distribuidora y Comercializadora Norte SA

Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)?

Pediatrix Medical Group (MD) reported stronger Q2 2026 results with increased sales and net income, leading to improved EPS from continuing operations. These results, along with the company's inclusion in Russell 2000 Defensive indexes, support its investment narrative of disciplined cost control in the …

Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD

Sei Investments Co. reduced its stake in Pediatrix Medical Group Inc. (NYSE:MD) by 19.3% in the first quarter, selling 37,564 shares and retaining 157,407 shares valued at $3.37 million. Despite institutional selling and buying from various firms, the company reported strong Q1 earnings of …

Onemednet director Thomas Kosasa buys $1 million in shares By Investing.com

OneMedNet Corp. director and 10% owner Thomas Kosasa recently invested $1 million in the company, acquiring 1,449,275 shares at $0.69 each. This purchase increased his direct beneficial ownership to over 18.5 million shares. Separately, OneMedNet announced over $3 million in new bookings for 2026, …

Noticias de acciones de Empresa Distribuidora y Comercializadora Norte SA (EDN)

OneMedNet (NASDAQ: ONMD) plans reverse stock split and adds 1M incentive shares

OneMedNet (NASDAQ: ONMD) is seeking stockholder approval for a reverse stock split at a ratio between 1-for-5 and 1-for-20 to regain compliance with Nasdaq's minimum bid price requirement. Additionally, the company plans to amend its 2022 Equity Incentive Plan to increase the share reserve …

OneMedNet (ONMD) insider invests $1,000,000 in new share subscription

OneMedNet Corp director and 10% owner Thomas Kosasa invested $1,000,000 in the company by purchasing 1,449,275 shares of common stock on July 30, 2026. The shares were acquired through a subscription agreement at $0.69 each, a price based on the volume-weighted average price for …

Onemednet Corp (ONMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Onemednet Corp (ONMD), focusing on its future EPS and revenue growth estimates. It briefly mentions the stock's current market data, including its closing price and market cap. The content appears to be a stub or a placeholder …

Price to earnings forward of OneMedNet Corp – NASDAQ:ONMD

This page provides financial information for OneMedNet Corp (NASDAQ: ONMD), specifically focusing on its forward price-to-earnings ratio. The content appears to be a snapshot from TradingView, displaying key financial metrics and offering tools for market analysis.

Empresa Distribuidora y Comercializadora Norte SA (EDN): Proyecciones de BPA Futuro y Evolución de Ventas

The article provides an earnings forecast for Empresa Distribuidora y Comercializadora Norte SA (EDN), noting its earnings forecast score of 8.00 and ranking 12th in the Electric Utilities & IPPs industry. Based on analysis from 2 analysts, the stock has an average price target …

Empresa Distribuidora y Comercializadora Norte SA (EDN) Stock News Today

Insiders At Pediatrix Medical Group Sold US$1.8m In Stock, Alluding To Potential Weakness

This article analyzes insider selling at Pediatrix Medical Group (NYSE:MD) totaling US$1.8m over the last year, particularly a large sale by the CEO, which could signal potential weakness in the company's future performance. Despite the stock price being down 23% in the past 12 …

Pediatrix Q2 2026 earnings: Reimbursement gains offset volume declines

Pediatrix Medical Group (NYSE: MD) reported a 4.0% year-over-year increase in Q2 2026 net revenue to $487.8 million, driven by recent acquisitions and improved reimbursement rates, despite a decline in patient volumes. While diluted GAAP EPS rose to $0.49, higher operating costs led to …

Pediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3%

Pediatrix Medical Group (NYSE:MD) reported Q2 CY2026 results that exceeded revenue and non-GAAP profit expectations, with sales up 4% year-on-year to $487.8 million and adjusted EPS of $0.63. Despite beating estimates, the stock dropped 12.3% post-announcement, indicating investor disappointment. The company highlighted strong performance …

Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook

Pediatrix Medical Group (NYSE: MD) reported Q2 revenue that beat analyst estimates, driven by recent acquisitions and improved reimbursement factors, despite a decrease in patient volumes. The company also reaffirmed its 2026 full-year Adjusted EBITDA outlook. Analysts currently rate the stock as a "buy" …

Earnings Flash (MD) Pediatrix Medical Group, Inc. Posts Q2 Adjusted EPS $0.63 per Share, vs. FactSet Est of $0.59

Pediatrix Medical Group, Inc. (MD) reported Q2 adjusted EPS of $0.63 per share, surpassing FactSet's estimate of $0.59. The article provides a snapshot of the company's recent performance and mentions its Q2 2026 earnings call scheduled for August 4, 2026. Further details about the …

MEDNAX ($MD) Releases Q2 2026 Earnings

Pediatrix Medical Group (NYSE:MD) Issues Quarterly Earnings Results

Enterprise value to EBITDA forward of OneMedNet Corp – BOATS:ONMDW

This article provides financial data for OneMedNet Corp (BOATS:ONMDW), specifically focusing on its Enterprise Value to EBITDA forward metric. The information is presented within a financial charting platform context, highlighting the company's financial performance.

Pediatrix Medical Group (MD) Q2 Earnings: What To Expect

Pediatrix Medical Group (MD) is set to report its Q2 earnings this Tuesday. The market expects a 1.9% year-on-year revenue growth, a turnaround from last year's decrease. The company has a strong track record of beating revenue estimates, and analysts have reconfirmed their expectations …